Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

XOMA Royalty (XOMAP)

XOMA Royalty Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XOMAP
DateTimeSourceHeadlineSymbolCompany
10/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Royalty Corporation
19/12/202412:30GlobeNewswire Inc.XOMA Royalty Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAPXOMA Royalty Corporation
02/12/202414:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Royalty Corporation
02/12/202412:30GlobeNewswire Inc.XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its PortfolioNASDAQ:XOMAPXOMA Royalty Corporation
13/11/202423:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Royalty Corporation
13/11/202423:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Royalty Corporation
07/11/202412:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Royalty Corporation
07/11/202412:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XOMAPXOMA Royalty Corporation
07/11/202412:30GlobeNewswire Inc.XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAPXOMA Royalty Corporation
22/10/202412:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Royalty Corporation
22/10/202412:00GlobeNewswire Inc.XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist BioscienceNASDAQ:XOMAPXOMA Royalty Corporation
23/09/202410:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Royalty Corporation
23/09/202410:30GlobeNewswire Inc.Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)NASDAQ:XOMAPXOMA Royalty Corporation
23/09/202409:30GlobeNewswire Inc.XOMA Royalty Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAPXOMA Royalty Corporation
04/09/202411:30GlobeNewswire Inc.XOMA Royalty to Present at Upcoming Investor Conferences in SeptemberNASDAQ:XOMAPXOMA Royalty Corporation
13/08/202411:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Royalty Corporation
13/08/202411:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XOMAPXOMA Royalty Corporation
13/08/202411:30GlobeNewswire Inc.XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAPXOMA Royalty Corporation
09/07/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Royalty Corporation
20/06/202411:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAPXOMA Royalty Corporation
18/06/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XOMAPXOMA Royalty Corporation
18/06/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XOMAPXOMA Royalty Corporation
13/06/202420:31Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XOMAPXOMA Royalty Corporation
12/06/202411:30GlobeNewswire Inc.XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review VoucherNASDAQ:XOMAPXOMA Royalty Corporation
30/05/202420:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Royalty Corporation
17/05/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Royalty Corporation
17/05/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Royalty Corporation
17/05/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Royalty Corporation
17/05/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Royalty Corporation
17/05/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Royalty Corporation
 Showing the most relevant articles for your search:NASDAQ:XOMAP

Your Recent History